Weeks after being arrested on charges of security fraud, Martin Shkreli, a Wall Street tycoon who gained notoriety for buying the rights of drugs and then dramatically raising their prices, received a subpoena to appear before a Congressional committee investigating price gouging in the pharmaceutical industry.
The House Committee on Oversight and Government Reform delivered a subpoena to Shkreli's attorneys, demanding his presence at a hearing on Tuesday, the New York Times reports.
The brash executive responded to the subpoena with characteristic nonchalance on Twitter:
Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.
Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
